Stem Cell Profits 5 Years Away Says Repair Stem Cell Institute Chairman!

Are you or a loved one interested in receiving stem cell treatment? For free information, please fill out our treatment form or email me don@repairstemcells.org and just put TREATMENT in the subject box and the MEDICAL CONDITION in the message.

Repair Stem Cell Institute Chairman-  that's me- Don Margolis!  I was just interviewed by The Wall Street Transcript (TWST)about my views on adult stem cells (aka Repair Stem Cells) and embryonic stem cells and how they both fit (or in the case of embryonic stem cells, don't fit) in the scheme of things in the world of investment.

The full interview is only available to  TWST subscribers (Sorry, I gave them my word).  However, I can share our press release regarding this interview:

According to Mr. Margolis, stem cell research companies that store
umbilical cord blood cells for future use will have "the best shot at
making the first profits once the public becomes aware how well these stem
cells work." The RSCI Chairman is the founder of TheraVitae, the first stem
cell company in the world to successfully treat dying heart patients with
Repair Stem Cells.

Update:  Early November 2008, Happily, I was wrong.  Osiris just received $130 million of what can potentially be 1.3 billion.

Among the other predictions Mr. Margolis made in this TWST financial
news interview were the following:

-- Wall Street has been discounting Embryonic Stem Cell (ESC) company
stocks from 2004 through this summer when these stocks hit new lows;

-- There are 2100 Adult Stem Cell clinical trials listed at
http://www.clinicaltrials.gov right now "for more diseases than I can count" said
Margolis, "and these clinical trials means two things: First, thousands and
thousands of human beings either have been treated, will be treated, or are
being treated in these clinical trials by the only stem cells with a chance
to improve their lives. Second, many powerful financial and investment
leaders are spending hundreds of millions of dollars to fund these trials.
They know that Repair Stem Cells are the future of medicine."

-- Margolis stated that "Embryonic Stem Cell (ESC) clinical trials are
somewhere in the distant future, waiting for someone to discover an ESC
which can be safely implanted into a human being." Six such attempts can be
found at http://www.clinicaltrials.gov, but no treatments are even being
considered.

I have more good stuff in the press release--

Click here to see the full press release on this fresh interview on stem cell profits